Intravenous lidocaine reduces systemic inflammation but not myocardial injury following thoracic surgery for lung cancer: a randomized controlled trial - PubMed
3 days ago
- #lidocaine
- #myocardial injury
- #thoracic surgery
- Intravenous lidocaine reduces systemic inflammation but not myocardial injury post thoracic surgery for lung cancer.
- The study was a randomized controlled trial approved by the Medical Ethics Committee of Shanghai Pulmonary Hospital.
- All procedures followed ethical standards, including the 1964 Helsinki Declaration, with informed consent from participants.
- The authors declared no competing interests.
- References cited include guidelines on non-cardiac surgery and studies on myocardial injury post-surgery.